Matthew Grist
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Synthetic Organic Chemistry Methods, Oxidative Organic Chemistry Reactions, Marine Sponges and Natural Products
Most-Cited Works
- → Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity(2016)707 cited
- → Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor(2014)591 cited
- → Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)(2013)258 cited
- → Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors(2017)78 cited
- → Dipeptidyl nitrile inhibitors of Cathepsin L(2009)67 cited
- → Synthetic studies on the DEF-rings of FR182877 and hexacyclinic acid(2004)30 cited
- → Synthesis of a model DEF-ring core of hexacyclinic acidElectronic supplementary information (ESI) available: experimental procedures and characterisation data. See http://www.rsc.org/suppdata/cc/b3/b303706a/(2003)27 cited
- → The Transcendental Turn(2015)20 cited
- → An iodocyclisation/elimination approach to a DEF-ring core of FR182877(2003)19 cited
- → Identification and optimisation of a series of N-(4-anilino-2-pyridyl)acetamide activin receptor-like kinase 1 (ALK1) inhibitors(2016)8 cited